大型重症监护患者队列中循环单核细胞HLA-DR表达的监测:与继发感染的关系
该观察性研究在外科ICU纳入1053例患者(592例有第二次mHLA-DR测量),首次测量在入院3天内、第二次在5-10天,用竞争风险模型分析mHLA-DR与ICU获得性感染(IAI)的关系。结果:223例(37.7%)发生IAI;初始mHLA-DR下降与后续IAI无关(p=0.721),但5-7天持续低mHLA-DR(<8000 AB/C)与后续IAI相关(p=0.01),两次测量间负斜率也与后续IAI显著相关(p=0.009)。第二次mHLA-DR联合入院SAPS II评分预测性能最佳,持续淋巴细胞减少和单核细胞减少与后续IAI无关。作者认为免疫监测应保留给最严重的患者。
要点
- 入院5-7天mHLA-DR持续<8000 AB/C与后续ICU获得性感染相关(p=0.01)。
- 首次与第二次mHLA-DR之间的负斜率与后续ICU获得性感染显著相关(p=0.009)。
- 入院初始mHLA-DR下降与后续ICU获得性感染无关(p=0.721)。
- 第二次mHLA-DR联合入院SAPS II评分的预测性能最佳,优于单独白细胞亚群计数。
- 持续淋巴细胞减少和单核细胞减少与后续ICU获得性感染无关。
适用人群与场景
- 法国一家三级医院外科ICU的成年重症患者,共纳入1053例,其中592例完成第二次mHLA-DR测量。
- 作者认为免疫监测应保留给入院时病情最严重的患者(高 severity score)。
诊断标准与关键阈值
- mHLA-DR低表达阈值:<8000 AB/C(抗原结合位点/细胞)。
- 首次mHLA-DR测量在入院后3天内,第二次在入院后第5至10天(持续低表达在入院第5至7天评估)。
研究设计与关键结果
- 研究类型:观察性研究,单中心(法国一家三级医院外科ICU),1053例患者,592例有第二次mHLA-DR测量。
- 223例(37.7%)发生ICU获得性感染(IAI)。
- 初始mHLA-DR下降与后续IAI无关(p=0.721)。
- 入院第5至7天持续低mHLA-DR(<8000 AB/C)与后续IAI相关(p=0.01)。
- 首次与第二次mHLA-DR之间的负斜率与后续IAI显著相关(p=0.009)。
- 第二次mHLA-DR联合入院SAPS II评分的预测性能最佳。
- 持续淋巴细胞减少和单核细胞减少与后续IAI无关。
证据类型、等级与局限
- 证据类型:观察性研究(单中心外科ICU队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为免疫监测应保留给入院时病情最严重的患者。
- 入院初始mHLA-DR下降不排除后续发生ICU获得性感染的可能。
- 入院7天内mHLA-DR下降或持续低于8000 AB/C与后续ICU获得性感染独立相关,预测性能优于单独白细胞亚群计数。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The reports of an early and profound acquired immunodepression syndrome (AIDs) in ICU patients had gained sufficient credence to modify the paradigm of acute inflammation. However, despite several articles published on AIDs and its assessment by monocytic HLA-DR monitoring, several missing informations remained: 1-Which patients' are more prone to benefit from mHLA-DR measurement, 2-Is the nadir or the duration of the low mHLA-DR expression the main parameter to consider? 3-What are the compared performances of leukocytes' count analyses (lymphocyte, monocyte).
MATERIAL AND METHOD: We conducted an observational study in a surgical ICU of a French tertiary hospital. A first mHLA-DR measurement (fixed flow cytometry protocol) was performed within the first 3 days following admission and a 2nd, between day 5 and 10. The other collected parameters were: SAPS II and SOFA scores, sex, age, comorbidities, mortality and ICU-acquired infections (IAI). The associations between mHLA-DR and outcomes were tested by adjusted Fine and Gray subdistribution competing risk models.
RESULTS: 1053 patients were included in the study, of whom 592 had a 2nd mHLA-DR measurement. In this cohort, 223 patients (37.7%) complicated by IAI. The initial decrement in mHLA-DR was not associated with the later occurrence of IAI, (p = 0.721), however, the persistence of a low mHLA-DR (< 8000 AB/C), measured between day 5 and day 7, was associated with the later occurrence of IAI (p = 0.01). Similarly, a negative slope between the first and the second value was significantly associated with subsequent IAI (p = 0.009). The best performance of selected markers was obtained with the combination of the second mHLA-DR measurement with SAPSII on admission. Persisting lymphopenia and monocytopenia were not associated with later occurrence of IAI.
CONCLUSION: Downregulation of mHLA-DR following admission is observed in a vast number of patients whatever the initial motif for admission. IAI mostly occurs among patients with a high severity score on admission suggesting that immune monitoring should be reserved to the most severe patients. The initial downregulation did not preclude the later development of IAI. A decreasing or a persisting low mHLA-DR expression below 8000AB/C within the first 7 days of ICU admission was independently and reliably associated with subsequent IAI among ICU patients with performances superior to leukocyte subsets count alone.
参考来源
- de Roquetaillade C, Dupuis C, Faivre V, et al. Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections. Ann Intensive Care. 2022. PMID: 35526199. doi:10.1186/s13613-022-01010-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。